A REVIEW ON PULSATILE DRUG DELIVERY SYSTEM
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2013, Vol 4, Issue 3
Abstract
Pulsatile Drug Delivery Systems are gaining a lot of interest as they deliver the drug at the right place at the right time and in the right amount, thus providing spatial and temporal delivery and increasing patient compliance. Pulsatile Drug Delivery systems (PDDS) are basically time-controlled drug delivery systems in which the system controls the lag time independent of environmental factors like pH, enzymes, gastro-intestinal motility, etc. These systems are designed according to the circadian rhythm of the body. The principle rationale for the use of pulsatile release of the drugs is where a constant drug release is not desired. A pulse has to be designed in such a way that a complete and rapid drug release is achieved after the lag time. Various systems like capsular systems, osmotic systems, single and multiple-unit systems based on the use of soluble or erodible polymer coating and use of rupturable membranes have been dealt with in the article. These systems are beneficial for the drugs having chronopharmacological behavior where night time dosing is required, such as anti-arhythmic and anti-asthmatic. Some of the disease conditions wherein PDDS are promising include duodenal ulcer, cardiovascular diseases, arthritis, asthma, diabetes, neurological disorder, cancer, hypertension and hypercholesterolemia. PDDS can be classified into time controlled systems wherein the drug release is controlled primarily by the delivery system, stimuli induced PDDS in which release is controlled by the stimuli, such as the pH or enzymes present in the intestinal tract or enzymes present in the drug delivery system and externally regulated system where release is programmed by external stimuli like magnetism, ultrasound, electrical effect and irradiation. Current review article discussed the reasons for development of pulsatile drug delivery system, types of the disease in which pulsatile release is required, classification, advantages, limitation, and Polymers used in pulsatile drug delivery system. To introduce the concept of chronotherapeutics, it is important to define the following concepts.
Authors and Affiliations
N. G. Rao, P. Soumya, K. Revathi, B. Nayak,
Keywords
Related Articles
- EP ID EP98541
- DOI 10.7897/2230-8407.04307
- Views 121
- Downloads 0
EFFECTS OF METHANOLIC EXTRACT OF ALPINIA GALANGA FROM MANIPUR (INDIA) ON UTERUS OF OVARIECTOMISED C3H ALBINO MICE
Methanolic extract of shade dried rhizome of Alpinia galanga (MAGE) was prepared using Soxhlet apparatus through a minimal of 18 hrs running. Working doses of the MAGE were determined after LD50 study selecting two dos...
EFFECT OF SOME HERBAL DRUGS ON HAEMATOLOGICAL PROFILES OF RATS
Excessive use of oestrogen or ethinyl oestradiol (EO, a semisynthetic 17b-oestradiol as highly potent oestrogen) can cause many detrimental effects, including cancer in humans as well as in animals. On the other hand, ma...
SOLID LIPID NANOPARTICLES AND NANO LIPID CARRIERS: AS NOVEL SOLID LIPID BASED DRUG CARRIER
Interest in lipid based drug delivery has developed over the past decade fuelled by a better understanding of the multiple roles lipids may play in enhancing oral bioavailability. Moreover, the emergence of novel excipie...
EFFECT OF KONDAGOGU ON THE RELEASE BEHAVIOUR OF AMBROXOL HYDROCHLORIDE MATRIX TABLETS
The aim of present research work was to study the effect of kondagogu on the release behavior of ambroxol hydrochloride sustained delivery dosage forms. Oral dosage forms containing 75mg Ambroxol hydrochloride in matrix...
PHARMACOLOGICAL SCREENING OF SOME NEW AMINOPYRIDINIUM DERIVATIVES
Aminopyridinium derivative such as Ethyl-2-(4-chloroamino pyridinium) acetate (compound A),Ethyl-2-(4-bromoamino pyridinium) acetate (compound B), Ethyl-2-(3-chloroaminopyridinium) acetate (compound C) have been evaluate...